Main > ONCOLOGY (**) > Brain Cancer>SEGA>TSC *** > Treatment > Co.: CH. N. Everolimus.
Co.: CH. N. Everolimus.'s subsections
(*) USA Approval Date: ?
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2016. 09.13.
TradeMark
TradeMark Web-Site
UpDate: 2017. 08.13
Co.: CH. N. Everolimus.'s products
This section has no products